Novel Data-Mining Methodologies for Adverse Drug Event Discovery and Analysis¶
Harpaz, R., DuMouchel, W., Shah, N. H., Madigan, D., Ryan, P., & Friedman, C. (2012). Novel Data-Mining Methodologies for Adverse Drug Event Discovery and Analysis. Clinical Pharmacology & Therapeutics, 91(6), 1010-1021.
Cited by¶
1 citation across 1 artifact.
Each citation links to the sentence it supports in the citing article.
Primes¶
- Parallel Independent Inspection
- In drug safety, post-market pharmacovigilance aggregates adverse-event reports from many physicians to surface signals invisible in any single trial.
This sourcePost-market pharmacovigilance aggregates spontaneous adverse-event reports from many physicians (e.g., FAERS) and applies disproportionality/signal-detection across enormous case volume to surface rare drug effects invisible in any single pre-market trial.
- In drug safety, post-market pharmacovigilance aggregates adverse-event reports from many physicians to surface signals invisible in any single trial.
Verification¶
This reference passed the adversarial substantiation pipeline: it was checked to exist and to support the claim it is attached to. See how references were verified.
Registry ID ref:c0111e3cebb7 · see in the full table